Coagulopathies in orthopaedics: Links to inflammation and the potential of individualizing treatment strategies

Journal of Orthopaedic Trauma

Volumn 27, Issue 4, 2013, Pages 236-241

  Stutz, Christopher M ^a   O'Rear, Lynda D ^a   O'Neill, Kevin R ^a   Tamborski, Maria E ^a   Crosby, Colin G ^a   Devin, Clinton J ^a   Schoenecker, Jonathan G ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute respiratory distress syndrome (ARDS); bleeding; coagulation; coagulopathy; DIC; DVT; fibrin; hematoma; heparin; hypercoagulability; hypocoagulability; infection; inflammation; protein C; pulmonary embolus; systemic inflammatory response syndrome (SIRS); thrombin generation; thrombosis; warfarin; wound healing

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING INHIBITOR; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN; THROMBOMODULIN; WARFARIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CAUSE OF DEATH; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; HEMATOMA; HUMAN; HYPERCOAGULABILITY; HYPOCOAGULABILITY; INFLAMMATION; LUNG EMBOLISM; MORBIDITY; MULTIPLE ORGAN FAILURE; MUSCULOSKELETAL INJURY; ORTHOPEDIC SURGERY; ORTHOPEDICS; PARTIAL THROMBOPLASTIN TIME; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTHROMBIN TIME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOSIS PREVENTION; TREATMENT DURATION; WOUND HEALING IMPAIRMENT;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; HUMANS; INFLAMMATION; MUSCULOSKELETAL SYSTEM; ORTHOPEDIC PROCEDURES; WOUNDS AND INJURIES;

EID: 84875832011     PISSN: 08905339     EISSN: 15312291     Source Type: Journal    
DOI: 10.1097/BOT.0b013e318269b782     Document Type: Article

References (40)

1. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-965.
2. Friedman RJ. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty. J Am Acad Orthop Surg. 2007;15:148-155.
3. Hirsh J, Guyatt G, Albers GW, et al. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:71S-109S.
4. Eikelboom JW, Karthikeyan G, Fagel N, et al. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009;135:513-520.
5. Gando S, Kameue T,Matsuda N, et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost. 2002;88:943-949.
6. Esmon CT. Coagulation inhibitors in inflammation. Biochem Soc Trans. 2005;33(pt 2):401-405.
7. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 suppl):S26-S34.
8. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2011;34(1):43-62.
9. Esmon CT. Role of coagulation inhibitors in inflammation. Thromb Haemost. 2001;86:51-56.
10. Ma L, Dorling A. The roles of thrombin and protease-activated receptors in inflammation. Semin Immunopathol. 2011.
11. Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg. 2011;254:10-19.
12. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009;49:2652-2660.
13. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma. 2009;67:266-275; discussion 275-276.
14. Selby R, Geerts W, Ofosu FA, et al. Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism. Thromb Res. 2009;124:281-287.
15. Golob JF Jr, Sando MJ, Kan JC, et al. Therapeutic anticoagulation in the trauma patient: is it safe? Surgery. 2008;144:591-596; discussion 596-597.
16. Street JT, McGrath M, O'Regan K, et al. Thromboprophylaxis using a low molecular weight heparin delays fracture repair. Clin Orthop Relat Res. 2000;381:278-289.
17. Civelek A, Ak K, Kurtkaya O, et al. Effect of a low molecular weight heparin molecule, dalteparin, on cellular apoptosis and inflammatory process in an incisional wound-healing model. Surg Today. 2007;37: 406-411.
18. Patel VP, Walsh M, Sehgal B, et al. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89:33-38.
19. Esmon CT. The protein C pathway. Chest. 2003;124(3 suppl):26S-32S.
20. Chesebro BB, Rahn P, Carles M, et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock. 2009;32:659-665.
21. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64:1211-1217; discussion 1217.
22. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245:812-818.
23. Machlus KR, Lin FC, Wolberg AS. Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice. Blood. 2011;118: 3960-3968.
24. Machlus KR, Cardenas JC, Church FC, et al. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood. 2011;117:4953-4963.
25. Drost AC, Burleson DG, Cioffi WG Jr, et al. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma. 1993;35:335-339.
26. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med. 1995;23:1835-1842.
27. Utter GH, Owings JG, Jacoby RC, et al. Injury induces increased monocyte expression of tissue factor: factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J Trauma. 2002;52:1071-1077; discussion 1077.
28. Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. J Crit Care. 2001;16:167-177.
29. Brouwer JL, Veeger NJ, Kluin-Nelemans HC, et al. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med. 2006;145:807-815.
30. Salvati EA, Della Valle AG, Westrich GH, et al. The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 2005;441: 40-55.
31. Varga E, Kujovich J. Management of inherited thrombophilia: guide for genetics professionals. Clin Genet. 2011.
32. Kitchens CS, Erkan D, Brandao LR, et al. Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group. Am J Med. 2011;124:290-296.
33. Lindahl TL, Lundahl TH, Nilsson L, et al. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee-a prospective study. Thromb Haemost. 1999;81:18-21.
34. Berntorp E, Salvagno GL. Standardization and clinical utility of thrombin- generation assays. Semin Thromb Hemost. 2008;34:670-682.
35. Hemker HC, Giesen P, AlDieri R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32:249-253.
36. Sheth NP, LJ, Della Valle CJ. DVT prophylaxis in total joint reconstruction. Orthop Clin North Am. 2010;41:273-280.
37. Friedman R. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty. J Am Acad Orthop Surg. 2007;15:148-155.
38. Burnett RS, Clohisy JC, Wright RW, et al. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty. 2007;22:317-324.
39. Johanson NA, Lachiewicz PF, Lieberman JR, et al. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009;17:183-196.
40. Wolberg AS. Thrombin generation assays: understanding how the method influences the results. Thromb Res. 2007;119:663-665.